Abstract. Increased vascular permeability and angiogenesis are hallmarks of the implantation process in the uterus. Angiomotin (Amot), which is a vascular angiogenesis-related protein, belongs to the motin family. There are two other members of the motin family, angiomotin-like 1 and 2 (Amotl1 and 2), which are also thought to be involved with angiogenesis. In the present study, the distribution of motin mRNAs in the mouse uterus during the peri-implantation period was investigated by in situ hybridization. Amot and Amotl1 were expressed in the stromal cells on days 3 and 4; expressions of Amotl2 during the same period were low. During the postimplantation period, Amot and Amotl1 were expressed in secondary decidual cells, while Amotl2 expression fell to an undetectable level. We also examined hormonal regulation of motin expression by steroid hormone treatment in ovariectomized mice. We found that expression of Amot was induced by P 4 in stromal cells. Additionally, Amotl1 expression was upregulated by both P 4 and estrogen (E 2 ) in stromal cells, whereas E 2 increased this gene expression for only a limited time; after 12 h, expression dissipated. In contrast, P 4 regulated the expression of Amotl2 in stromal cells, while E 2 regulated its expression in luminal epithelium cells. Our results demonstrated that Amot, Amotl1, and Amotl2 were differentially expressed in uterine cells during the peri-implantation period, and that their expressions were differentially regulated by P 4 and E 2 . Key words: Angiomotin, Amotl1, Amotl2, Steroid hormone, Uterus (J. Reprod. Dev. 58: [649][650][651][652][653] 2012) S ynchronization of embryonic development and uterine differentiation to its receptive state is necessary to establish a successful pregnancy. Uterine receptivity for implantation lasts for a limited period of time in mice [1] [2] [3] . In this state, the uterine environment is able to support blastocyst growth, attachment and the subsequent events of implantation. The major hormones that specify uterine receptivity are the ovarian steroids progesterone (P 4 ) and estrogen. The uterus is pre-receptive on day 3 of pregnancy (day 1 = vaginal plug) and enters the receptive phase on day 4 under the influence of rising P 4 and a small amount of estrogen secretion on the morning of day 4 [4, 5] . Because P 4 and estrogen primarily target the uterus to regulate its functions during the peri-implantation period, it is thought that these hormones also modulate angiogenesis and decidualization in the uterus during pregnancy [6] [7] [8] .
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Angiogenesis physiologically occurs in the uterus during pregnancy [9, 10] . Increased uterine vascular permeability and angiogenesis are two hallmarks of the implantation process. The proangiogenic factor Vegf (vascular endothelial growth factor) and its receptor Flk1 (vascular endothelial growth factor receptor-2) are primarily important for uterine vascular permeability and angiogenesis prior to and during the attachment phase of the implantation process [6, 9] . Meanwhile, Vegf in complementation with the angiopoietins (Ang-1 and Ang-2) and their receptor Tie2 (endothelial-specific receptor tyrosine kinase) directs angiogenesis during decidualization [9, 11] . Ang-1 in collaboration with Vegf induces vessel maturation and maintains vessel leakiness, whereas Ang-2 induces vessel destabilization required for further sprouting in the presence of Vegf. Furthermore, hypoxia-inducible factors (HIFs) and cyclooxygenase-2 (Cox-2)-derived prostaglandins are important for uterine angiogenesis during implantation and decidualization by inducing the expression level of Vegf [11, 12] .
Steroid hormones are known to modulate the uterine angiogenic status via the Vegf system. We previously showed that the effects of estrogen and P 4 on angiogenic status in the uterus are different. In fact, estrogen promotes uterine vascular permeability but profoundly inhibits angiogenesis, whereas P 4 stimulates angiogenesis with little effect on vascular permeability [6] . These effects are mediated by differential spatiotemporal expression of proangiogenic factors [6] . However, the mechanisms for how estrogen and P 4 differently regulate uterine angiogenesis remain unclear.
Angiomotin (Amot) is a vascular angiogenesis-related protein that was initially identified as an angiogenesis inhibitor angiostatin-binding protein through a yeast two-hybrid screen [13, 14] . Amot can induce endothelial cell migration and tubule formation and therefore promotes angiogenesis [13, 15] . There are also two angiomotin-like proteins, Amotl1 and Amotl2. These three proteins belong to a motin family with a highly conserved coil-coil domain, PDZ binding domain and glutamine-rich domain [14] . Amotl1 and Amotl2 also likely play important roles in cell migration and angiogenesis [16] [17] [18] [19] . However, it is not yet known whether motin family proteins are expressed and, if so, how these expressions are regulated in the uterus during the peri-implantation period.
In the present study, we examined the distribution of motin mRNAs in the mouse uterus during the peri-implantation period. We also examined the ovarian hormonal regulation for the expression of motins. Our results demonstrate that P 4 and estrogen regulate differential expression of the motin family in the mouse uterus in a spatiotemporal manner.
Materials and Methods

Mice
Adult ICR mice were purchased from Japan SLC (Shizuoka, Japan) and bred in our animal care facility. Three-to five-month-old virgin females were mated with fertile males of the same strain to induce pregnancy (day 1 = vaginal plug). The experimental procedures were performed in accordance with the instructions of the Guide for the Care and Use of Laboratory Animals published by Utsunomiya University.
In situ hybridization
In situ hybridization was performed as described previously [11, 20] . The probes were generated by PCR cloning using specific primers. Primer sets for mouse-specific cDNAs to Amot (GenBank accession number NM_153319), Amotl1 (GenBank accession number BC055117), and Amotl2 (GenBank accession number NM_019764) were designed as follows: Amot, 5′-cctgctactgtttctccaac-3′ (forward) and 5′-tgaatgggtgtctttctttc-3′ (reverse); Amotl1, 5′-agatgagaacagaggctgaa-3′ (forward) and 5′-aaacctgctaaaaggcaaag-3′ (reverse); and Amotl2, 5′-caacagtagccagaggacac-3′ (forward) and 5′-tccttcctcattgtcatagg-3′ (reverse). Probes were inserted into pCRII-TOPO (Invitrogen, Carlsbad, CA, USA) or pBluescript II SK + vectors (Agilent Technologies, Santa Clara, CA, USA), and 35 S-labeled cRNA probes were generated by transcription with T3 or Sp6 polymerase. Probes had specific activities of about 2 × 10 9 dpm/μg. Uterine tissues were snap-frozen using freezing solution (FREEZER, HOZAN, Osaka, Japan) as described previously [21, 22] . Frozen sections (10 μm) were prepared with a cryostat, mounted onto poly-L-lysine-coated slides and fixed in cold 4% paraformaldehyde in phosphate-buffered saline. The sections were prehybridized and hybridized at 45 C for 4 h in a 50% formamide hybridization buffer containing the 35 S-labeled antisense cRNA probes. After hybridization, sections were incubated with RNase A (20 µg/ml) at 37 C for 20 min, and RNase A-resistant hybrids were detected by autoradiography using Kodak NTB-2 liquid emulsion (Eastman Kodak, Rochester, NY, USA). Sections were developed after several days of exposure. The exposure times were the same for the pictures in each Figure (Figs. 1-5 ). Sections were post-stained with eosin and hematoxylin. Sections hybridized with the sense probes did not result in any positive hybridization.
Hormonal treatments
Hormonal treatment was performed as described previously [20] . To examine the effects of P 4 and/or E 2 (estradiol-17β) on uterine gene expression, adult mice were ovariectomized and rested for 2 weeks. Mice were subcutaneously injected with sesame oil (0.1 ml/ mouse), P 4 (2 mg/mouse), E 2 (100 ng/mouse) or P 4 plus E 2 . The steroids were dissolved in sesame oil. At 2, 6, 12 and 18 h after injection, collected uterine tissues were snap-frozen using freezing solution as described above and processed for in situ hybridization.
Results
Amot, Amotl1, and Amotl2 were expressed in the preimplantation uteri in a spatiotemporal manner
We examined the expression of Amot, Amotl1 and Amotl2 in the uterus on days 1-4 of pregnancy by in situ hybridization (Fig. 1) . All three motins were expressed in the luminal epithelium on day 1 of pregnancy, whereas they were differentially expressed in the uterus from days 2 to 4. Amot was expressed in the luminal epithelium on day 2 of pregnancy and in the stroma on days 3 and 4. Amotl1 was expressed in the stroma from days 2 to 4. Low expression of Amotl2 was observed in the stroma throughout the preimplantation period. These results indicate that expression patterns of motins were different in the uterus during the pre-implantation period except on day 1 of pregnancy.
Motins were differentially expressed in postimplantation uteri
We next examined expression of the motin family in the uterus during the postimplantation period. Amot was expressed in stoma cells on days 5 and 6, while its expression was localized in secondary decidual cells and undifferentiated stromal cells away from the implanting embryo on days 7 and 8 (Fig. 2) . Amotl1 expression was primarily observed in decidual cells close to the implanting embryo along the mesometrial and antimesometrial poles on day 5, whereas the expression was localized in secondary decidual cells on days 6 to 8. Although Amotl2 expression was observed in stroma on day 5, the expression was very low to undetectable on days 6 to 8. These results suggest that Amot and Amotl1 most likely play a physiological role in proliferation and differentiation of uterine cells in a spatiotemporal manner during the postimplantation period.
Uterine expression of Amot, Amotl1, and Amotl2 is regulated by P 4 and E 2
We further examined how, if at all, ovarian hormones regulate the expression of these genes in a more defined system, i.e., in ovariectomized mice after steroid hormone treatment. While Amot expression was low to modest in stromal cells in ovariectomized uteri treated with oil (vehicle control), this expression was increased in stromal cells at 6 h after P 4 injection; increased expression was maintained until 24 h after P 4 injection (Fig. 3) . In contrast, Amot expression was faint to low in E 2 -treated uteri. The combined injection of P 4 and E 2 resulted in an accumulation pattern similar to that of P 4 alone. These results indicate that P 4 upregulates the uterine expression of Amot, whereas E 2 has no effect on the expression of this gene.
Amotl1 expression was very low to undetectable in ovariectomized uteri treated with oil (Fig. 4) . The expression of Amotl1 was induced in stromal cells at 6 h after P 4 injection, and higher expression was observed at 12 and 24 h. Injection of E 2 increased Amotl1 expression in stromal cells at 2 and 6 h, although this expression was decreased after 12 h. The combination treatment of P 4 and E 2 induced Amotl1 expression in stromal cells, while higher expression was observed from 6 to 24 h. These results suggest that both P 4 and E 2 upregulate Amotl1 expression in the uterus, whereas E 2 increases this gene expression for only a limited time.
Amotl2 expression was very low to undetectable in ovariectomized uteri treated with oil (Fig. 5) . The expression of Amotl2 was increased by P 4 in stromal cells at 12 and 24 h. In contrast, E 2 injection increased Amotl2 expression in the luminal epithelium. Combined injection of P 4 and E 2 induced Amotl2 expression in both the luminal epithelium and stromal cells. These results indicate that Amotl2 expression in the uterus is differentially regulated by P 4 and E 2 , i.e., P 4 regulates the expression of Amotl2 in stromal cells, while E 2 regulates its expression in luminal epithelium cells.
Discussion
Under physiological conditions, angiogenesis occurs primarily in the uterus in the adult during the reproductive cycle and pregnancy. The uterine angiogenic status is modulated by steroid hormones such as P 4 and estrogen [6] . Although the motin family is associated with angiogenesis [15, 18, 19] , their expression and hormonal regulation in the uterus have never been examined during peri-implantation in the mouse. In the present study, we demonstrated that differential expression and distribution of motins were regulated by P 4 and E 2 in the uterus.
Our present study showed that Amot was expressed in the luminal epithelium on days 1 and 2 of pregnancy and in stromal cells on days 3 and 4. During the peri-implantation period, rising levels of P 4 secreted from freshly formed corpora lutea initiate stromal cell proliferation from day 3 onward [5] . Indeed, our defined system of hormone treatment for ovariectomized mice demonstrated that P 4 induced Amot expression in stromal cells. These results indicate that P 4 is an upregulator for the uterine expression of Amot during the preimplantation period. In contrast, during the postimplantation, Amot was expressed in stoma cells on days 5 and 6, while its expression was localized in secondary decidual cells and undifferentiated stromal cells away from the implanting embryo on days 7 and 8. Therefore, Amot expression may be associated with proliferation and/ or differentiation of uterine cells. It has been reported that Amot is a vascular angiogenesis-related protein [13, 14] . Uterine angiogenesis dependent on Vegf and Flk1 is involved in the attachment phase of the implantation process [9] . Furthermore, angiogenic status via the Vegf system is modulated by steroid hormones [6] . Therefore, Amot expression upregulated by P 4 most likely plays a physiological role in angiogenesis of uterine cells during peri-implantation in the mouse. Expression of Amotl1 was localized in the luminal epithelium on day 1 of pregnancy, and in stromal cells from days 2 to 4. Hormone treatment for ovariectomized mice demonstrated that both P 4 and E 2 upregulate Amotl1 expression in stromal cells, whereas E 2 increases this gene expression for only a limited time. During the peri-implantation period, after the start of P 4 secretion from day 3 onward, stromal cell proliferation is further stimulated by a small amount of ovarian E 2 secreted on the morning of day 4 of pregnancy [5] . These coordinated effects of P 4 and E 2 stop uterine epithelial cell proliferation and initiate differentiation. During normal pregnancy, an active blastocyst in the uterus stimulates implantation. After attachment is initiated on day 4 at 2400 h, stromal cells surrounding the implanting blastocyst begin to proliferate extensively and differentiate into decidual cells [2] . Our present study during the postimplantation period showed that Amotl1 expression was primarily observed in decidual cells close to the implanting embryo along the mesometrial and antimesometrial poles on day 5, whereas the expression was localized in secondary decidual cells on days 6 to 8. These results suggest that both P 4 and E 2 are upregulators for the uterine expression of Amotl1 and are associated with proliferation and/or differentiation of uterine cells, including angiogenesis during the preimplantation period in mice.
Amotl2 expression was localized in the luminal epithelium on day 1 of pregnancy, whereas the expression was low from days 2 to 4. On the first day of pregnancy in mice, preovulatory E 2 secretion induces proliferation of uterine epithelial cells, and rising levels of P 4 secreted from freshly formed corpora lutea initiate stromal cell proliferation from day 3 onward [5] . Our hormone treatment for ovariectomized mice demonstrated that P 4 regulates the expression of Amotl2 in stromal cells, while E 2 regulates its expression in luminal epithelium cells. These results suggest that Amotl2 expression in the uterus is differentially regulated by P 4 and E 2 in luminal epithelium and stromal cells during the preimplantation period. In contrast, during the postimplantation period, Amotl2 expressions were very low to undetectable. These results suggest that neither P 4 nor E 2 is associated with Amotl2 expression during the postimplantation period. The phylogenetic analysis and the localization of splice sites support the conclusion that Amotl2 is an outgroup in relation to Amot and Amotl1, although both Amotl1 and Amotl2 contain a polyglutamic acid repeat at an N-terminal region [14] . Our findings of differential expression of Amotl2 suggest that this gene function could be different from other motins in the uterus during the peri-implantation period.
In conclusion, our present investigation offers several new observations including differential expression of the motin family in the uterus during the peri-implantation period. Specifically, differential expressions of motins were regulated by ovarian steroid hormones. These observations may help to elucidate the mechanisms behind differentiation, proliferation, and angiogenesis of uterine cells that allow for the establishment of pregnancy.
